首页>
外国专利>
MONOCLONAL ANTIBODY BASED BIOMARKER DISCOVERY AND DEVELOPMENT PLATFORM
MONOCLONAL ANTIBODY BASED BIOMARKER DISCOVERY AND DEVELOPMENT PLATFORM
展开▼
机译:基于单克隆抗体的生物标志物发现与开发平台
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method or platform for monoclonal antibody based biomarker discovery is disclosed. The method according to the invention provides for the integration of analyte collection, hybridoma screening and nanovolume integrated mass spectrometry (NVIMS) to achieve a robust screening system that is capable, for example, of cutting 4-6 years off of the classical biomarker discovery and development process. The invention provides a platform for the rapid, high-throughput production, isolation and characterization of, e.g., disease specific biomarkers together with highly specific monoclonal antibodies. The method of the invention has a variety of applications such as, but not limited to, drug testing, biohazard applications, ecological applications, physilogical applications and/or pathology screening applications. The method of the invention is also capable of being performed or used as or with a high-throughput screening process or system of the invention.
展开▼